Nuvectis Pharma Inc (NVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 7,794 | 6,595 | 5,568 | 6,449 | 4,359 |
| Operating Income | -7,794 | -6,595 | -5,568 | -6,449 | -4,359 |
| Other Income | 332 | 261 | 236 | 201 | 206 |
| Pre-tax Income | -7,462 | -6,334 | -5,332 | -6,248 | -4,153 |
| Net Income Continuous | -7,462 | -6,334 | -5,332 | -6,248 | -4,153 |
| Net Income | $-7,462 | $-6,334 | $-5,332 | $-6,248 | $-4,153 |
| EPS Basic Total Ops | -0.44 | -0.30 | -0.27 | -0.36 | -0.24 |
| EPS Basic Continuous Ops | -0.33 | -0.30 | -0.27 | -0.36 | -0.24 |
| EPS Diluted Total Ops | -0.44 | -0.30 | -0.27 | -0.36 | -0.24 |
| EPS Diluted Continuous Ops | -0.33 | -0.30 | -0.27 | -0.36 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -0.44 | -0.30 | -0.27 | -0.36 | -0.24 |
| EBITDA(a) | $-7,794 | $-6,595 | $-5,568 | $-6,449 | $-4,359 |